Fundz

Laboratoires Pierre Fabre Appoints Nicolas Zombré as Chief Executive Officer

Aug 25, 2026

Position

Chief Executive Officer

Company

Pierre Fabre Laboratories

Nicolas Zombré
ManufacturingBiotechnologyHealth Carepharmaceuticals

Description

Laboratoires Pierre Fabre has announced the appointment of Nicolas Zombré as Chief Executive Officer of its U.S. Dermocosmetics operations. Zombré will lead the company's U.S

Quick answer

Laboratoires Pierre Fabre Appoints Nicolas Zombré as Chief Executive Officer (August 25, 2026).

Who is the new Chief Executive Officer at Pierre Fabre Laboratories?
Pierre Fabre Laboratories named Nicolas Zombré Chief Executive Officer, announced August 25, 2026.
What did Pierre Fabre Laboratories announce on August 25, 2026?
Laboratoires Pierre Fabre has announced the appointment of Nicolas Zombré as Chief Executive Officer of its U.S. Dermocosmetics operations.
What does Pierre Fabre Laboratories do?
Pierre Fabre Laboratories is a leading French medical and beauty care company with over 4 decades of experience in innovation, development, manufacturing, and commercialization in oncology.
Which similar companies made leadership changes around the same time?
Cipla (July 23, 2026), Electromed (August 25, 2026), Amplio Spine (August 25, 2026) and Lonza (August 26, 2026) also announced leadership changes within 45 days of Pierre Fabre Laboratories.

Source: Fundz verified event record.

Other recent leadership changes in pharmaceuticals and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Pierre Fabre Laboratories, and when

A new leader at Pierre Fabre Laboratories brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Pierre Fabre Laboratories raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pierre Fabre Laboratories, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pierre Fabre Laboratories. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pierre Fabre Laboratories

Location

3 Avenue Hubert Curien

About

Pierre Fabre Laboratories is a leading French medical and beauty care company with over 4 decades of experience in innovation, development, manufacturing, and commercialization in oncology. The company dedicated about 80% of its R&D spendings to oncology in 2022 and has declared targeted therapies as its main R&D priority. Its current commercial portfolio in oncology covers colorectal, breast and lung cancers, melanoma, hematology, and pre-cancerous skin conditions like actinic keratosis. In 2022, Pierre Fabre Laboratories posted 2.7 billion euros in revenues, 69% of which came from international sales in 120 countries. Established in the South-West of France since its creation in 1962, the Group manufactures over 90% of its products in France and employs some 9,600 people worldwide. The company is 86%-owned by the Pierre Fabre Foundation, a government-recognized public-interest foundation, and secondarily by its own employees through an international employee stock ownership plan. Pierre Fabre Laboratories' sustainability policy has been assessed by the independent AFNOR Certification body at the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development). Further information about Pierre Fabre Laboratories can be found at www.pierre-fabre.com, @PierreFabre.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pierre Fabre Laboratories changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Pierre Fabre Laboratories's next move

Learn about Strategic plan

Pierre Fabre Laboratories changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.